August 29, 2025

Gastrointestinal Foreign Bodies: When to Use Computed Tomography Versus Radiograph

A physician-focused review of gastrointestinal foreign body ingestion is looking to guide triage and intervention.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

CD68/CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma, Study

Skeletal classic Hodgkin lymphoma shows a macrophage-rich, B-cell–poor microenvironment, with high CD68/CD163 linked to worse survival.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 26, 2025

Mapping Immune Markers in Rare Thymic Tumors

High PD-L1 expression in thymic carcinomas may support its inclusion in routine histopathologic evaluation

The Pathologist

August 22, 2025

New CT Score Tracks Pneumonia Stage Progression

Researchers validate a visual CT scoring system designed to improve classification of pneumonia-related lung changes in clinical and research settings.

Conexiant

August 22, 2025

Seven-Factor Tool Improves Sepsis Death Prediction

An admission-based model predicted 28-day mortality more accurately than SOFA and APACHE II, offering a potential tool for early risk stratification in ICU patients with sepsis secondary to pneumonia.

Conexiant

August 22, 2025

Linear Hyperpigmentation After Chemotherapy: What's Your Diagnosis?

A 15-year-old girl developed distinctive, painless, whip-like streaks across her trunk and back after receiving combination chemotherapy for ovarian yolk sac tumor. What’s your diagnosis?

Conexiant

August 22, 2025

Personalizing First-Line Therapy in NSCLC: Plasma-Guided Adaptive Treatment Approach

In patients with newly diagnosed, PD-L1–positive, advanced non–small cell lung cancer (NSCLC) who tested negative for driver mutations, implementation of plasma-guided treatment intensification—from m...

The ASCO Post